MyBlueDots

ALAMEDA, Calif.–(BUSINESS WIRE)–Exelixis, Inc. (Nasdaq: EXEL) today announced its preliminary unaudited financial results for the fiscal year 2024, provided financial guidance for fiscal year 2025 and delivered an update on its business. Exelixis anticipates 2025 will be a year of clinical and regulatory execution and continued growth for its cabozantinib franchise, as well as multiple data readouts for zanzalintinib and across its diversified pipeline of small molecules and biotherapeutics w

MARLBOROUGH, Mass.–(BUSINESS WIRE)—- $HOLX #earnings–Hologic Announces Preliminary Revenue Results for First Quarter of Fiscal 2025

VENLO, Netherlands–(BUSINESS WIRE)—- $QGEN #QIAGEN–QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a new plan to return up to approximately $300 million (maximum EUR 281 million) to shareholders through a synthetic share repurchase that combines a direct capital repayment with a reverse stock split. This new repurchase comes after QIAGEN returned approximately $300 million to shareholders in early 2024 through a synthetic share repurchase. Together, these two programs represent $600 m

REDWOOD CITY, Calif.–(BUSINESS WIRE)–N-Power Medicine, a company leading the reinvention of the clinical trial process, today announced the acquisition of Syapse Holdings Inc. (“Syapse”), a pioneer in precision medicine solutions for community cancer centers. The integration of Syapse into N-Power Medicine incorporates Syapse’s extensive network of community-based health systems, with more than 1,000 oncologists, its data and technology stack, and its dedicated team. N-Power partners with com

LOS ANGELES–(BUSINESS WIRE)–Prospect Medical Holdings, Inc. (“Prospect Holdings” or the “Company”) today announced that it is proceeding on a strategic pathway to realign its organizational focus outside of California, including pursuit of an agreement to sell the Roger Williams Medical Center and Our Lady of Fatima Medical Center in Rhode Island to Centurion Foundation, Inc. (the “Rhode Island Transaction”). Prospect Holdings is also continuing to engage with key stakeholders outside of Rhod